Sinovac Biotech EPS of $0.04

Sinovac Biotech (SVA): Q3 EPS of $0.04.

Revenue of $22.1M (+54.5% Y/Y). (PR)

From other sites
Comments (1)
  • 11146471
    , contributor
    Comments (1373) | Send Message
    SVA has became profitable and still their growth potential is huge!
    26 Jan 2014, 05:20 AM Reply Like
DJIA (DIA) S&P 500 (SPY)
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs